Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Prevalidation of Salivary Biomarkers for Oral Cancer Detection

Open access
Elashoff, David, Zhou, Hui, Reiss, Jean, Wang, Jianghua, Xiao, Hua, Henson, Bradley, Hu, Shen, Arellano, Martha, Sinha, Uttam, Le, Anh, Messadi, Diana, Wang, Marilene, Nabili, Vishad, Lingen, Mark, Morris, Darly, Randolph, Timothy, Feng, Ziding, Akin, David, Kastratovic, Dragana A., Chia, David, Abemayor, Elliot, Wong, David T.W. · 2012 · Cancer Epidemiology, Biomarkers & Prevention

Abstract

Background: Oral cancer is the sixth most common cancer with a 5-year survival rate of approximately 60%. Presently, there are no scientifically credible early detection techniques beyond conventional clinical oral examination. The goal of this study is to validate whether the seven mRNAs and three proteins previously reported as biomarkers are capable of discriminating patients with oral squamous cell carcinomas (OSCC) from healthy subjects in independent cohorts and by a National Cancer Institute (NCI)-Early Detection Research Network (EDRN)-Biomarker Reference Laboratory (BRL). Methods: Three hundred and ninety-five subjects from five independent cohorts based on case controlled design were investigated by two independent laboratories, University of California, Los Angeles (Los Angeles, CA) discovery laboratory and NCI-EDRN-BRL. Results: Expression of all seven mRNA and three protein markers was increased in OSCC versus controls in all five cohorts. With respect to individual marker performance across the five cohorts, the increase in interleukin (IL)-8 and subcutaneous adipose tissue (SAT) was statistically significant and they remained top performers across different cohorts in terms of sensitivity and specificity. A previously identified multiple marker model showed an area under the receiver operating characteristic (ROC) curve for prediction of OSCC status ranging from 0.74 to 0.86 across the cohorts. Conclusions: The validation of these biomarkers showed their feasibility in the discrimination of OSCCs from healthy controls. Established assay technologies are robust enough to perform independently. Individual cutoff values for each of these markers and for the combined predictive model need to be further defined in large clinical studies. Impact: Salivary proteomic and transcriptomic biomarkers can discriminate oral cancer from control subjects. Cancer Epidemiol Biomarkers Prev; 21(4); 664–72. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-11-1093

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 185

Metadata

Authors
Elashoff, D., Zhou, H., Reiss, J., Wang, J., Xiao, H., Henson, B., Hu, S., Arellano, M., Sinha, U., Le, A., Messadi, D., Wang, M., Nabili, V., Lingen, M., Morris, D., Randolph, T., Feng, Z., Akin, D., Kastratovic, D. A., Chia, D., Abemayor, E., & Wong, D. T. W.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2012-03-28
Volume
21
Issue
4
Pages
664-672
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2123575729
Cited by
185
References
2
FWCI
14.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalidation of Salivary Biomarkers for Oral Cancer Detection. https://app.cochat.ai/papers/10.1158/1055-9965.epi-11-1093
The paper
Elashoff, D., Zhou, H., Reiss, J., Wang, J., Xiao, H., Henson, B., Hu, S., Arellano, M., Sinha, U., Le, A., Messadi, D., Wang, M., Nabili, V., Lingen, M., Morris, D., Randolph, T., Feng, Z., Akin, D., Kastratovic, D. A., . . . Wong, D. T. W. (2012). Prevalidation of Salivary Biomarkers for Oral Cancer Detection. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-11-1093

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.